Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Clin Neuropharmacol ; 36(2): 55-8, 2013.
Article in English | MEDLINE | ID: mdl-23503548

ABSTRACT

OBJECTIVE: Although the unfavorable effects of early antiepileptic drugs, valproic acid, and carbamazepine (CBZ) on cognitive functions and visual functions have been investigated, the unfavorable effects of levetiracetam (LEV) on cognitive and visual functions remain unknown. The aim of the present study is to investigate whether there is a difference between the adverse effects by comparing the P300 and P100 latencies of LEV with epileptic patients using CBZ or sodium valproate (VPA) and healthy subjects. METHOD: A control group of 20 healthy subjects and 53 patients receiving monotherapy with CBZ (n = 15), VPA (n = 14), and LEV (n = 24) who admitted to neurology policlinic for investigation and treatment were enrolled in this study. Visual evoked potentials and event-related evoked potentials were studied according to these groups. Standard "oddball paradigm" (unpredictable stimuli series) was used to obtain P300. RESULTS: The P300 latencies of epileptic patients receiving CBZ, VPA, and LEV were longer compared with the control group, and the differences were statistically significant (P = 0.001, 0.001, and 0.03, respectively). The P300 latency of patients receiving LEV was significantly shorter than the group receiving CBZ and VPA with statistically significant difference (P < 0.01 for both). The P300 amplitude was lower in the groups receiving CBZ, VPA, and LEV compared with the control group, and the difference was statistically significant (P < 0.05). CONCLUSIONS: The present study shows that LEV disrupts P300 latency less than VPA and CBZ and does not prolong P100 as much as them.


Subject(s)
Carbamazepine/pharmacology , Epilepsy/drug therapy , Event-Related Potentials, P300/drug effects , Evoked Potentials, Visual/drug effects , Piracetam/analogs & derivatives , Valproic Acid/pharmacology , Adolescent , Adult , Anticonvulsants/pharmacology , Anticonvulsants/therapeutic use , Carbamazepine/therapeutic use , Epilepsy/physiopathology , Event-Related Potentials, P300/physiology , Evoked Potentials, Visual/physiology , Female , Humans , Levetiracetam , Male , Middle Aged , Piracetam/pharmacology , Piracetam/therapeutic use , Treatment Outcome , Valproic Acid/therapeutic use , Young Adult
2.
Neurol Sci ; 32(5): 849-54, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21720897

ABSTRACT

Objective of this study was to determine which nerve conduction is more sensitive electrophysiologically in the diagnosis of polyneuropathy in diabetics by evaluating the sensory conduction in medial plantar nerve and medial peroneal (dorsal) cutaneous nerves. Additionally to investigate the relation between Neuropathy Symptom Score (NSS) and Neuropathy Disability Score (NDS) values used in the diagnosis of these conduction studies. Forty patients with diagnosis diabetic neuropathy were included into this study. In diabetic polyneuropathic patient group, both medial plantar and medial dorsal cutaneous nerve sensory action potential were not bilaterally obtained in 19 patients (47.5%). Sensitivity and specificity of medial dorsal cutaneous nerve and medial plantar nerve sensory conduction abnormalities in diagnosis of diabetic polyneuropathy were higher compared to sural nerve conduction abnormalities. This study showed that both medial plantar and medial dorsal cutaneous nerve conduction study performed bilaterally was a highly sensitive and specific method in diagnosis of diabetic neuropathy.


Subject(s)
Diabetic Neuropathies/diagnosis , Electrodiagnosis/methods , Neural Conduction/physiology , Peroneal Nerve/physiopathology , Polyneuropathies/diagnosis , Tibial Nerve/physiopathology , Action Potentials/physiology , Adult , Diabetic Neuropathies/physiopathology , Female , Foot/innervation , Foot/physiopathology , Humans , Male , Middle Aged , Neurologic Examination , Polyneuropathies/physiopathology
3.
Clin Neurophysiol ; 118(9): 2005-8, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17644037

ABSTRACT

OBJECTIVE: Calcium channel blockers are commonly used in some cardiovascular disorders. These drugs can act at neuromuscular transmission, at both pre- and postsynaptic levels and may produce neuromuscular dysfunction. Therefore, they may result in misdiagnosis in electrophysiological testing of healthy subjects. This study aimed to investigate the influence of calcium channel blockers on neuromuscular transmission, using single fiber electromyography, in subjects who were healthy excepting controlled arterial hypertension condition. METHODS: Single fiber electromyography during voluntary contraction of the extensor digitorum communis muscle, nerve conduction studies of upper and lower extremities, and concentric needle electromyography of the extensor digitorum communis were performed on 16 verapamil users, 16 amlodipine users, and 16 age-matched normal controls. Twenty potential pairs were recorded from each subject. Twenty individual jitter values and a mean jitter value were calculated for each subject. Both mean jitter values and numbers of abnormal individual jitter values were compared in verapamil and amlodipine users versus normal controls. RESULTS: Eight of 16 verapamil users and 7 of amlodipine users showed evident neuromuscular transmission abnormalities by single fiber electromyography. Two subjects from verapamil and one subjects from amlodipine users group had borderline dysfunction of neuromuscular transmission. CONCLUSIONS: These results suggest that both verapamil and amlodipine impair neuromuscular transmission in subjects without neuromuscular disease. SIGNIFICANCE: The effects of verapamil and amlodipine are at a level, which may cause misinterpretation of single fiber electromyography studies carried out to investigate neuromuscular junction disorders.


Subject(s)
Amlodipine/adverse effects , Calcium Channel Blockers/adverse effects , Hypertension/drug therapy , Hypertension/physiopathology , Neuromuscular Junction/physiopathology , Synaptic Transmission/drug effects , Verapamil/adverse effects , Adult , Amlodipine/therapeutic use , Calcium Channel Blockers/therapeutic use , Electromyography , Female , Fingers , Humans , Male , Middle Aged , Muscle Contraction/drug effects , Muscle, Skeletal/innervation , Muscle, Skeletal/physiopathology , Verapamil/therapeutic use
4.
Auton Neurosci ; 134(1-2): 81-4, 2007 Jul 31.
Article in English | MEDLINE | ID: mdl-17395550

ABSTRACT

This study aimed to investigate the changes of habituations in the autonomic function of patients suffering from migraine or tension type headache through sympathetic skin responses. Patients with migraine without aura (n=26), with episodic tension type headache without migraine (n=28) and 30 healthy controls were studied. During continuous stimulation, four blocks of 20 responses were sequentially recorded. Mean amplitude changes in the second, third and fourth blocks are expressed as the percentages of the first block. In both headache groups, there was a lack of habituation compared to the control group.


Subject(s)
Habituation, Psychophysiologic/physiology , Migraine without Aura/physiopathology , Skin/innervation , Sympathetic Nervous System/physiopathology , Tension-Type Headache/physiopathology , Adult , Electric Stimulation , Female , Humans , Male
5.
Arch Gynecol Obstet ; 275(4): 255-61, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17047975

ABSTRACT

Hormone replacement therapy has been widely used for the prevention of postmenopausal osteoporosis and treatment of climacteric symptoms for many years, but its effect on ocular functions remains unclear. The aim of the study was to evaluate the long-term effects of tibolone on ocular functions in postmenopausal women. A total of 77 healthy women with at least 1 year of spontaneous menopause were enrolled in the study. Forty women were treated with tibolone for 6 months and 37 women were left untreated. All these patients underwent ophthalmic examination including visual acuity, intraocular pressure (IOP), tear functions, blue-on-yellow and white-on-white Humphrey visual field (HVF), visual evoked potentials (VEP) and electroretinography (ERG). There were significant differences in mean deviation of blue-on-yellow HVF, and oscillatory potentials (O1, O2, and O4) in the ERGs of the chronic tibolone users and the control (P < 0.0001, P = 0.001, P < 0.0001 and 0.05, respectively). However, no significant differences were observed in visual acuity, IOP, tear functions, white-on-white HVF and VEP. We concluded that, although tibolone had no effects on visual acuity, IOP, tear functions and VEP, it might cause some early adverse effects on the electrophysiologic and structural characteristics of the retina, which are detected by these sensitive assays. Randomized placebo-controlled studies with larger groups are needed in future research.


Subject(s)
Electroretinography/drug effects , Estrogen Receptor Modulators/adverse effects , Evoked Potentials, Visual/drug effects , Norpregnenes/adverse effects , Visual Fields/drug effects , Estrogen Receptor Modulators/administration & dosage , Female , Hormone Replacement Therapy , Humans , Middle Aged , Norpregnenes/administration & dosage , Postmenopause , Vision Screening
6.
Ann Vasc Surg ; 18(3): 343-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15354637

ABSTRACT

Spinal cord ischemia still remains an unsolved problem in modern aortic surgery. In this study, we investigated the effectiveness of combined agents such as adenosine and L-carnitine infused to the isolated segment of abdominal aorta in a rabbit model. Twenty-eight rabbits divided into four groups underwent 40 min of isolated infrarenal aortic occlusion. Group I animals received no medication. Group II received an infusion of 100 mg/kg L-carnitine in normothermic saline over the first 10 min of ischemia. Group III received 50 mg adenosine, and group IV received a combination of the two agents in the same fashion. Spinal cord function was evaluated at 24 and 72 hr after operation on the basis of Tarlov scale and similar results were obtained. After a second evaluation, spinal cords were harvested for histological examination. Group I animals were all paraplegics. Spinal cord function was partially intact in two of the group II animals with Tarlov scores of 5 in two and 4 in two whereas one of the rabbits could not hop with a score of 3, and the remaining two could not sit with scores of 1 and 0. The spinal cord function of group III animals was intact with Tarlov scores of 5 in three, 4 in two, and 3 and 1 in remaining ones. In the group IV animals, it was fully intact with Tarlov scores of 5. Histological examination in group I revealed marked enlargement of the vacuoles of glial cells in the white matter of spinal cord. Glial cells were deteriorated in some locations in group II whereas they were mostly protected in the third group. In group IV, histological examination revealed no evidence of spinal cord injury. In conclusion, combined infusion of adenosine and L-carnitine provided better protection against postischemic spinal cord injury than individual infusion of these agents.


Subject(s)
Adenosine/pharmacology , Carnitine/pharmacology , Sodium Chloride/pharmacology , Spinal Cord Injuries/etiology , Spinal Cord Injuries/prevention & control , Spinal Cord Ischemia/complications , Spinal Cord Ischemia/drug therapy , Vasodilator Agents/pharmacology , Animals , Axons/pathology , Blood Pressure/physiology , Disease Models, Animal , Female , Infusions, Intra-Arterial , Male , Models, Cardiovascular , Neuroglia/pathology , Neuroprotective Agents/pharmacology , Paraplegia/physiopathology , Paraplegia/prevention & control , Rabbits , Reperfusion Injury/complications , Reperfusion Injury/drug therapy , Reperfusion Injury/physiopathology , Spinal Cord Injuries/physiopathology , Spinal Cord Ischemia/physiopathology , Time Factors
7.
Headache ; 42(7): 582-7, 2002.
Article in English | MEDLINE | ID: mdl-12482209

ABSTRACT

OBJECTIVE: To investigate the effects of fluoxetine in migraine prophylaxis on habituation of visually evoked potentials. BACKGROUND: Habituation of pattern reversal visually evoked potentials was found to be abnormal in migraine between attack, and this abnormality was most likely due to serotonergic pathway dysfunction in the brain stem. METHODS: One hundred nineteen subjects were included in the study: 40 healthy volunteers and 79 migraineurs not taking any prophylactic migraine medication (44 without aura and 35 with aura). Visually evoked potentials in migraineurs were recorded in the headache-free interval. Amplitude change of the visually evoked potentials (N1-P1) was measured between the first and fifth block of 50 sequential averagings during continuous stimulation at 3.1 Hz. All migraineurs were placed on fluoxetine 20 mg/day for prophylaxis of migraine. One month later, visually evoked potentials were recorded again. RESULTS: Mean amplitude changes in the fifth block expressed as percentages of the first block were -13.4% +/- 19.2% in healthy volunteers, 9.8% +/- 23.3% in migraine without aura, and 4.4% +/- 8.7% in migraine with aura during the baseline period. The difference was significant between migraineurs and healthy volunteers (both P= 0.0001), but not between migraineur groups. After treatment, amplitude changes were -9.3% +/- 14.5% in migraine without aura and -10.1% +/- 11.5% in migraine with aura. Habituation pattern tended to normalize with prophylactic treatment, and mean amplitude changes were not significant between migraineurs and healthy volunteers (both P = 0.4). CONCLUSIONS: We concluded that the fluoxetine prophylaxis corrects the interictal deficit of habituation in migraineurs.


Subject(s)
Evoked Potentials, Visual/drug effects , Fluoxetine/pharmacology , Habituation, Psychophysiologic/drug effects , Migraine Disorders/prevention & control , Selective Serotonin Reuptake Inhibitors/pharmacology , Adult , Female , Fluoxetine/adverse effects , Fluoxetine/therapeutic use , Humans , Male , Migraine Disorders/physiopathology , Nausea/chemically induced , Selective Serotonin Reuptake Inhibitors/adverse effects , Selective Serotonin Reuptake Inhibitors/therapeutic use , Sleep Stages/drug effects , Treatment Outcome
8.
Brain Dev ; 24(7): 681-7, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12427514

ABSTRACT

UNLABELLED: To evaluate central nervous system functioning involvement in nocturnal enuresis, P300 and N200 event-related brain potentials and brainstem auditory-evoked potentials (BAER) were assessed in a group of 35 enuretic boys aged 7-9 years. The measurements of enuretic group were compared to those of age and sex matched non-enuretics. P300 latency in the enuretic group was significantly longer than in non-enuretic group (420 ms at parietal scalp (Pz), 414 ms at central scalp (Cz) versus 386 ms at Pz, 376 ms at Cz; P < 0.01 and P < 0.01, respectively). Both enuretic and non-enuretic subjects were divided into three subgroups his age. There was no significant difference in terms of both P300 amplitude and N200 latency and N200 amplitude between non-enuretic age subgroups. But, P300 latency over central scalp in 8 years old non-enuretic subgroup was significantly longer than in 9 years old non-enuretic subgroup (P < 0.01). No significant difference was found in latency and amplitude of P300 and N200 latency between enuretic subgroups. However, N200 amplitude at Cz in 8 years old enuretic subgroup was significantly lower than both in 7 years old enuretic subgroup and in 9 years old enuretic subgroup (P < 0.01 and P < 0.01, respectively). There were significant topographical differences in latency and amplitude of P300 and in N200 latency in enuretic age subgroups, only. There was no significant difference in interpeak latencies I-III, I-V and III-V and wave latencies I, III and V of BAERs between enuretic group and non-enuretic subgroup. Longer interpeak and wave latencies of BAERs were found both in 8 years old enuretic subgroup and 8 years old non-enuretic subgroup. CONCLUSION: Longer P300 latency in primer enuretics compare to non-enuretics is an evidence of a maturational delay of central nervous system functioning.


Subject(s)
Enuresis/physiopathology , Evoked Potentials, Auditory, Brain Stem/physiology , Evoked Potentials/physiology , Age Factors , Child , Electroencephalography , Event-Related Potentials, P300/physiology , Humans , Male
9.
Curr Eye Res ; 24(4): 253-62, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12324863

ABSTRACT

PURPOSE: To investigate the retinal toxicity of different doses of intravitreal injections of levofloxacin in a rabbit model, which is the levorotatory component of ofloxacin and approximately twice as potent as ofloxacin and highly active in vitro against gram-positive and -negative bacteria, and anaerobic bacteria including many ocular pathogens. METHODS: Sixteen albino rabbits were used in this study, and divided four groups. Levofloxacin in doses of 50, 100, 250 and 500 microg was injected into the midvitreous of rabbit's left eyes. The other eye served as a control and received normal saline solution. Indirect ophthalmoscopy, electroretinography (ERG) and light microscopy were used for retinal toxicity of levofloxacin. ERGs were recorded before injection and at 1(st) day, 1(st), 2(nd) and 4(th) weeks. At the end of follow-up period, the rabbits were killed and the eyes were enucleated for histologic evaluation. RESULTS: Intravitreal injections of 50, 100, 250 and 500 microg levofloxacin did not cause any deterioration of the a-wave, b-wave or oscillatory potentials of ERG throughout the follow-up period of 4 weeks. No evidence of retinal toxicity was observed by indirect ophthalmoscopy and light microscopy in any case. CONCLUSIONS: In therapeutic doses of 500 microg or less, intravitreal levofloxacin does not have retinal toxicity in rabbit eyes and this dose was well above the MIC(90) values of ocular pathogens that cause endophthalmitis. If future studies in other species confirm our findings, intravitreal levofloxacin may be a potentially important drug in the treatment and prevention of clinical bacterial endophthalmitis.


Subject(s)
Anti-Infective Agents/administration & dosage , Levofloxacin , Ofloxacin/administration & dosage , Retina/drug effects , Animals , Anti-Infective Agents/poisoning , Dose-Response Relationship, Drug , Injections , Ofloxacin/toxicity , Rabbits , Retina/pathology , Retina/physiopathology , Vitreous Body
10.
J Clin Neurosci ; 9(3): 247-50, 2002 May.
Article in English | MEDLINE | ID: mdl-12093128

ABSTRACT

Gamma-aminobutyric acid-induced ion transport changes in the retinal pigment epithelium are described. Valproate acts as an inhibitor of gamma-aminobutyric acid transaminase. The purpose of this study was to investigate whether early visual impairment is related to valproate in patients with and without visual symptoms. Thirty-two patients, presenting with a history of seizures currently being treated with valproate, were included in the study. A complete clinical neuroophthalmologic examination was performed, including electroretinogram and visual field test. The electroretinogram parameters of epileptic patients were compared with those of 28 age- and sex-matched healthy volunteers. There was no significant difference in ERG parameters between the two groups. The visual field and visual acuity of all patients were within normal limits. When valproate is not used in conjunction with other antiepileptic drugs and serum levels are within therapeutic levels, it does not cause electrophysiologically detectable retinal dysfunction or any functional defect in visual perception that can be determined clinically.


Subject(s)
Anticonvulsants/adverse effects , Epilepsy/drug therapy , Epilepsy/physiopathology , Valproic Acid/adverse effects , Vision Disorders/chemically induced , Vision, Ocular , Adolescent , Adult , Anticonvulsants/therapeutic use , Electroretinography , Female , Humans , Male , Reference Values , Retinal Diseases/chemically induced , Valproic Acid/therapeutic use , Visual Acuity , Visual Fields
SELECTION OF CITATIONS
SEARCH DETAIL
...